PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ)
$7.17 -0.07 (-0.9669%)
Analysed PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) News Sources
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2026 Financial Results
23-04-2026
yahoo.com
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
06-05-2026
yahoo.com
Puma Biotechnology Reports First Quarter 2026 Financial Results
07-05-2026
yahoo.com
Puma Biotech (PBYI) Reports Q1 Loss, Tops Revenue Estimates
07-05-2026
yahoo.com
Puma Biotechnology, Inc. Q1 2026 Earnings Call Summary
08-05-2026
moby.co
PBYI Q1 Earnings & Sales Beat Estimates, 2026 Guidance Raised
08-05-2026
yahoo.com
Puma Biotechnology Q1 Earnings Call Highlights
08-05-2026
marketbeat.com
Puma (PBYI) Q1 2026 Earnings Call Transcript
08-05-2026
fool.com
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
11-05-2026
yahoo.com
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
14-05-2026
yahoo.com
What is the current price of PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ)?
The current price of PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) is $7.17.
PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) absolute price change since previous trading day?
The absolute price change of PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) since the previous trading day is $-0.07.
PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) percentage price change since previous trading day?
The percentage price change of PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) since the previous trading day is -0.9669%.
What is the most recent average sentiment score for PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ)?
The most recent average sentiment score for PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) is 63 out of 100.
What is the most recent average sentiment for PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ)?
The most recent sentiment for PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ) is .
SEC-8K** Filing Available For PUMA BIOTECHNOLOGY INC (PBYI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.